update from section chief
endocrinology & metabolism
John Wysolmerski, MD
A
fter a year-long nationwide search, John Wysolmerski, MD, was appointed chief
of the Section of Endocrinology & Metabolism in June 2021. Wysolmerski and section leadership have remained true to the mission of the Section of Endocrinology and Metabolism throughout the years: to improve the health and well-being of patients with endocrine and metabolic diseases by advancing scientific knowledge; by skillfully applying new knowledge to the care of patients; and by training the next generation of physician-scientists. After Robert Sherwin, MD, retired as section chief, faculty members developed
40
annual report 2021
a five-year plan to expand the section’s clinical practice with these goals in mind: to better capitalize on new educational and research opportunities within the growing Yale New Haven Health System; to enhance its educational programs with a better organized curriculum and new fellowship training opportunities; and to grow and broaden its research base by recruiting new physician-scientists. As section chief, Wysolmerski has brought together a leadership team to help the
section accomplish its collective goals. The leadership team members are Silvio Inzucchi, MD, who continues to serve as clinical chief; Renata Belfort de Aguiar, MD, PhD, who serves as associate chief for Diversity, Equity and Inclusion; Richard Kibbey, MD, PhD, and Jonathan Bogan, MD, who are co-associate chiefs for research; and Barbara Gulanski, MD, MPH, who serves as associate chief for education.
